THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $941,032 | -16.6% | 109,042 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,128,585 | -4.6% | 109,042 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,183,106 | -23.8% | 109,042 | -21.2% | 0.00% | 0.0% |
| Q4 2022 | $1,553,319 | +13.2% | 138,442 | +2.3% | 0.00% | 0.0% |
| Q3 2022 | $1,372,000 | +15.9% | 135,342 | +3.6% | 0.00% | 0.0% |
| Q2 2022 | $1,184,000 | -5.2% | 130,642 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,249,000 | -6.9% | 130,642 | +7.7% | 0.00% | 0.0% |
| Q4 2021 | $1,341,000 | +52.2% | 121,342 | +1.9% | 0.00% | 0.0% |
| Q3 2021 | $881,000 | -49.0% | 119,042 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,728,000 | -17.3% | 119,042 | +16.3% | 0.00% | 0.0% |
| Q1 2021 | $2,089,000 | +17.5% | 102,342 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $1,778,000 | +20.2% | 100,042 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,479,000 | -27.5% | 100,042 | +2.9% | 0.00% | -50.0% |
| Q2 2020 | $2,041,000 | +7.0% | 97,242 | +17.8% | 0.00% | 0.0% |
| Q1 2020 | $1,908,000 | -9.4% | 82,542 | +1.5% | 0.00% | 0.0% |
| Q4 2019 | $2,106,000 | +36.8% | 81,342 | +2.9% | 0.00% | 0.0% |
| Q3 2019 | $1,540,000 | +21.9% | 79,042 | +2.2% | 0.00% | +100.0% |
| Q2 2019 | $1,263,000 | -31.0% | 77,342 | -4.2% | 0.00% | -50.0% |
| Q1 2019 | $1,830,000 | -8.3% | 80,742 | +3.6% | 0.00% | -33.3% |
| Q4 2018 | $1,995,000 | -18.7% | 77,942 | +3.7% | 0.00% | 0.0% |
| Q3 2018 | $2,455,000 | +44.1% | 75,142 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $1,704,000 | -6.5% | 75,142 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,822,000 | -8.4% | 75,142 | +5.3% | 0.00% | 0.0% |
| Q4 2017 | $1,990,000 | -18.5% | 71,342 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $2,443,000 | -11.3% | 71,342 | +3.2% | 0.00% | 0.0% |
| Q2 2017 | $2,755,000 | +16.1% | 69,142 | +7.3% | 0.00% | 0.0% |
| Q1 2017 | $2,373,000 | +17.5% | 64,442 | +1.7% | 0.00% | 0.0% |
| Q4 2016 | $2,019,000 | -0.2% | 63,342 | +13.4% | 0.00% | 0.0% |
| Q3 2016 | $2,024,000 | +65.4% | 55,842 | +3.5% | 0.00% | +50.0% |
| Q2 2016 | $1,224,000 | +50.0% | 53,942 | +19.8% | 0.00% | +100.0% |
| Q1 2016 | $816,000 | +52.5% | 45,042 | +38.0% | 0.00% | 0.0% |
| Q4 2015 | $535,000 | +49.0% | 32,642 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $359,000 | +5.6% | 32,642 | +24.9% | 0.00% | 0.0% |
| Q2 2015 | $340,000 | -25.1% | 26,142 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $454,000 | +16.4% | 26,142 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $390,000 | -35.3% | 26,142 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $603,000 | -27.6% | 26,142 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $833,000 | – | 26,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |